---
title: "TUS-PHARMA issued a profit warning, expecting a net loss of 115 million to 149 million yuan for the fiscal year 2024, turning from profit to loss year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/226183372.md"
description: "According to the Zhitong Finance APP, TUS-PHARMA released its performance forecast for 2024, expecting a net loss attributable to shareholders of the listed company of between 115 million yuan and 149 million yuan, a year-on-year turnaround from profit to loss. During the reporting period, affected by market environment and other factors, the company's total operating revenue declined compared to the same period last year, coupled with rising prices of some raw and auxiliary materials, leading to a decrease in overall gross profit margin and profitability"
datetime: "2025-01-24T15:11:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/226183372.md)
  - [en](https://longbridge.com/en/news/226183372.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/226183372.md)
generator: "portal-rs"
---

# TUS-PHARMA issued a profit warning, expecting a net loss of 115 million to 149 million yuan for the fiscal year 2024, turning from profit to loss year-on-year

According to the Zhitong Finance APP, TUS-PHARMA (000590.SZ) released its performance forecast for 2024, expecting a net loss attributable to shareholders of the listed company of between 115 million yuan and 149 million yuan, a year-on-year turnaround from profit to loss. During the reporting period, affected by market environment and other factors, the company's total operating revenue declined compared to the same period last year, coupled with rising prices of some raw and auxiliary materials, leading to a decrease in overall gross profit margin and profitability

### Related Stocks

- [000590.CN](https://longbridge.com/en/quote/000590.CN.md)

## Related News & Research

- [Nvidia has lost $2 trillion in value. Here's what options traders expect from earnings](https://longbridge.com/en/news/305815593.md)
- [MPs ask what the break clause was for as Palantir wins two more years in the NHS](https://longbridge.com/en/news/305803837.md)
- [Elizabeth Warren Targets CVS, UnitedHealth and Cigna, Says Healthcare Giants ‘Take a Cut at Every Step’ as She Calls for Breaking Up Conglomerates](https://longbridge.com/en/news/305798081.md)
- [Nvidia shares set for $335 billion swing after earnings, options show](https://longbridge.com/en/news/305809285.md)
- [Lumentum ranked among Forbes America’s Best Companies](https://longbridge.com/en/news/305716406.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**